- Release of a humoral circulating cardioprotective factor by remote ischemic preconditioning is dependent on preserved neural pathways in diabetic patients. Jensen RV, Støttrup NB, Kristiansen SB, Bøtker HE. Basic Res Cardiol.2012;170(5):285

- Exercise-induced cardioprotection is mediated by a bloodborne, transferable factor. Michelsen MM, Støttrup NB, Schmidt MR, Løfgren B, Jensen RV, Tropak M, St-Michel EJ, Redington AN, Bøtker HEBasic Res Cardiol 2012;107(3):260

- Impact of O-GlcNAc on cardioprotection by remote ischaemic preconditioning in non-diabetic and diabetic patients. Jensen RV, Zachara NE, Nielsen PH, Kimose HH, Kristiansen SB, Bøtker HE. Cardiovasc Res.2013 1;97(2):369-78

- Ischemic preconditioning increases myocardial O-GlcNAc glycosylation. Jensen RV, Johnsen J, Kristiansen SB, Zachara NE, Bøtker HE. Scand Cardiovasc J. 2013;47(3):168-74

- Aldehyde dehydrogenase-2 inhibition blocks remote preconditioning in experimental and human models. Contractor H, Støttrup NB, Cunnington C, Manlhiot C, Diesch J, Ormerod JO, Jensen R, Bøtker HE, Redington A, Schmidt MR, Ashrafian H, Kharbanda RK. Basic Res Cardiol.2013;108(3):343

- Prostacyclins have no direct inotropic effect on isolated atrial strips from the normal and pressure overloaded human right heart. Holmboe S, Andersen A, Jensen RV, Kimose HH, Ilkjær LB, Shen L, Clapp LH, Nielsen-Kudsk JE. Pulm Circ 2017;7(2):339-347

- Effects of hypoglycemia on myocardial susceptibility to ischemia-reperfusion injury and preconditioning in hearts from rats with and without type 2 diabetes. Pælestik KB, Jespersen NR, Jensen RV, Johnsen J, Bøtker HE, Kristiansen SB. Cardiovasc Diabetol. 2017 Nov 9;16(1):148

- Influence of diabetes mellitus duration on the efficacy of ischemic preconditioning in a Zucker diabetic fatty rat model. Hjortbak MV, Hjort J, Povlsen JA, Jensen RV, Støttrup NB, Laursen MR, Jespersen NR, Løfgren B, Bøtker HE. PLoS One. 2018 Feb 23;13(2):e0192981